Scarica l'app Stockscreener
61.90
2.50%
1.51
Pre-mercato:
61.53
-0.37
-0.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché INSP Giù?
Forum
Previsione
Precedente Chiudi:
$60.39
Aprire:
$59.42
Volume 24 ore:
828.79K
Relative Volume:
0.52
Capitalizzazione di mercato:
$1.77B
Reddito:
$861.31M
Utile/perdita netta:
$53.12M
Rapporto P/E:
35.86
EPS:
1.7262
Flusso di cassa netto:
$85.01M
1 W Prestazione:
-9.25%
1M Prestazione:
-32.89%
6M Prestazione:
-29.93%
1 anno Prestazione:
-65.63%
Intervallo 1D:
$59.42
$62.53
Intervallo di 1 settimana:
$53.11
$64.30
Portata 52W:
$53.11
$197.75
Inspire Medical Systems Inc Stock (INSP) Company Profile
Nome
Inspire Medical Systems Inc
Settore
Industria
Telefono
763-957-5037
Indirizzo
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
61.90 | 1.73B | 861.31M | 53.12M | 85.01M | 1.7262 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Downgrade | Truist | Buy → Hold |
| 2025-12-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Aggiornamento | Truist | Hold → Buy |
| 2025-11-25 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-11-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-22 | Downgrade | UBS | Buy → Neutral |
| 2025-09-02 | Iniziato | Evercore ISI | Outperform |
| 2025-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Downgrade | Truist | Buy → Hold |
| 2024-11-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-05-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-04-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2024-01-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-12-13 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-11-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-11-03 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Iniziato | JP Morgan | Overweight |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-15 | Iniziato | Goldman | Buy |
| 2020-06-18 | Reiterato | Piper Sandler | Overweight |
| 2020-05-18 | Iniziato | Lake Street | Buy |
| 2020-04-28 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Iniziato | Piper Sandler | Overweight |
| 2020-01-28 | Iniziato | Oppenheimer | Underperform |
| 2020-01-27 | Iniziato | Oppenheimer | Underperform |
| 2019-11-06 | Aggiornamento | Berenberg | Sell → Hold |
| 2019-02-05 | Iniziato | Dougherty & Company | Buy |
| 2018-11-28 | Iniziato | Berenberg | Sell |
| 2018-10-29 | Iniziato | Leerink Partners | Outperform |
| 2018-05-29 | Iniziato | Guggenheim | Buy |
| 2018-05-29 | Iniziato | Stifel | Buy |
| 2018-05-29 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Inspire Medical Systems Inc Borsa (INSP) Ultime notizie
5 Insightful Analyst Questions From Inspire Medical Systems's Q4 Earnings Call - Finviz
Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Wolfe Research downgrades Inspire Medical Systems (INSP) - MSN
5 Insightful Analyst Questions From Inspire Medical Systems’s Q4 Earnings Call - Yahoo Finance
M&G PLC Increases Position in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems, Inc. $INSP Shares Acquired by Illinois Municipal Retirement Fund - MarketBeat
Aberdeen Group plc Raises Stock Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Wellington Management Group LLP Acquires Significant Stake in Inspire Medical Systems Inc - GuruFocus
Inspire Medical Systems (NYSE:INSP) Short Interest – NYSE Composite - Kalkine Media
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating a 38.65% Potential Upside in the Dynamic Medical Devices Sector - DirectorsTalk Interviews
Short Interest in Inspire Medical Systems, Inc. (NYSE:INSP) Increases By 31.1% - MarketBeat
Inspire Medical Systems Inc. (INSP) Confronts Near-Term Headwinds Despite Profitability - Insider Monkey
10 Best Medical Technology Stocks to Invest In - Insider Monkey
Is Inspire Medical Systems Inc. stock dividend yield sustainableTrade Analysis Summary & Community Verified Trade Signals - mfd.ru
Why is Inspire Medical Systems Inc. stock going downRate Hike & Community Trade Idea Sharing Platform - mfd.ru
Can Inspire Medical Systems Inc. (2DR) stock retain market dominanceJuly 2025 Gainers & Stock Timing and Entry Methods - mfd.ru
Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook - MSN
Technical Reactions to INSP Trends in Macro Strategies - Stock Traders Daily
Inspire Medical Systems, Inc. Just Beat EPS By 401%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Results: Inspire Medical Systems, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Thrivent Financial for Lutherans Has $1.44 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Decoding Inspire Medical Systems Inc (INSP): A Strategic SWOT In - GuruFocus
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc.INSP - Morningstar
Inspire Medical Systems, Inc. SEC 10-K Report - TradingView
Inspire Medical Systems, Astrana Health, Evolent Health, Corcept, and Centene Stocks Trade Up, What You Need To Know - Yahoo Finance
INSP Downgraded to Peer Perform by Wolfe Research | INSP Stock N - GuruFocus
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail
6.4 Million Medicare Recipients Face New Hurdles in Getting Care - AOL.com
Inspire Medical Systems (NYSE:INSP) Downgraded to Hold Rating by Robert W. Baird - MarketBeat
Inspire Medical Systems (NYSE:INSP) Lowered to "Hold" Rating by Wells Fargo & Company - MarketBeat
Wolfe Research downgrades Inspire Medical Systems stock rating to Peerperform - Investing.com Canada
Inspire Medical Systems stock hits 52-week low at $56.17 By Investing.com - Investing.com Canada
Piper Sandler lowers Inspire Medical Systems stock price target on reimbursement concerns - Investing.com Nigeria
Baird downgrades Inspire Medical stock to Neutral on reimbursement concerns - Investing.com Nigeria
What the FDA’s 2026 Update Means for Wearables - AOL.com
Jefferies Lowers Price Target for INSP, Keeps Hold Rating | INSP Stock News - GuruFocus
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $66.00 by Analysts at Jefferies Financial Group - MarketBeat
Analyst Shagun Singh Maintains Rating for Inspire Medical Systems (INSP) | INSP Stock News - GuruFocus
Stifel lowers Inspire Medical Systems stock price target on reimbursement issues - Investing.com Canada
Inspire Medical: Still A Long Way From A Good Night’s Sleep (NYSE:INSP) - Seeking Alpha
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Finviz
Inspire Medical Systems Lowers FY2026 Revenue Guidance After CMS Coding Clarification, Oppenheimer Says - marketscreener.com
INSP Stock Falls Despite Q4 Earnings Beat, Gross Margin Expands - TradingView
Inspire Medical Systems (NYSE:INSP) Shares Gap Down on Analyst Downgrade - MarketBeat
Piper Sandler Lowers Price Target for INSP to $85, Maintains Ove - GuruFocus
Wells Fargo Downgrades INSP to Equal-Weight, Lowers Price Target - GuruFocus
INSP: Mizuho Lowers Price Target to $85, Maintains Outperform Ra - GuruFocus
Inspire Medical Systems stock hits 52-week low at $56.17 - Investing.com
INSP Q4 Deep Dive: Reimbursement Uncertainty Shapes Outlook Despite Strong Product Adoption - Finviz
This Inspire Medical Systems Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
Truist Cuts Price Target on Inspire Medical Systems to $70 From $96, Keeps Hold Rating - marketscreener.com
Inspire Medical Systems Inc Azioni (INSP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):